Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of APOL1 Gene Variants in African American Kidney Transplant Recipients: A Study of Clinical Outcomes and Molecular Mechanisms

NCT01442402 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT01442402
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01442402 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of APOL1 Gene Variants in African American Kidney Transplant Recipients: A Study of Clinical Outcomes and Molecular Mechanisms
Lead sponsor
Brigham and Women's Hospital
Phase
Observational
Overall status
Terminated
Start date
April 30, 2014
Completion date
April 30, 2014
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney disease, kidney failure, chronic, transplant;failure,kidney